The above chart presents the market trend analysis for m s snam pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 12 transactions, with a transaction quantity of 4448 and a transaction weight of 0.
Product description
ORNIBRON H120+D274 LYOPH. FOR SUSP. FOR DOMESTIC FOWL 10 X 1000 D QTY: 2000 PCS / NET WT: 134 KGS (DETAIL AS PER INVOICE AND PACKING LIST)
Expand
Product description
BIOCAN DHPPI+LR INJECTION SICC. AD US. VET. 10 X 1 D QTY: 1500 PCS / NET WT: 203 KGS (DETAIL AS PER INVOICE AND PACKING LIST)
Expand
Product description
01...EGG JET PRINTER MODEL EGG-JET BAN5-20 SERIES 20 POWER 230V/50HZ BRAND NUOVO AG ORIGIN SWITZERLAND QTY = 01 SET WITH ALL ASSCEESORIES DETAILS ..(i)…ROLLERBELT …(ii)…40ML CARTRIDGE YC N01 FOOD GRADE INK GREEN AND RED (iii)…COMMUNICATION CAB
Expand
Product description
ORNIMIX CLONE B1+H120 Lyoph. for prepar. of sespen. for chicken 10 x 1000 d. QTY 2000 PCS (DETAIL AS PER INVOICE / PACKING LIST)
Expand
+View All
Partners
Total 10
RankCompanyTransactionsPerDetail
1vicam a waters
united statessupplier,they trade on 2025-12-17
5544.35%
>
2bioveta
russiasupplier,they trade on 2026-03-30
1713.71%
>
3bioveta a.s.
russiasupplier,they trade on 2026-02-23
1411.29%
>
m s snam pharma is pakistan Buyer&Supplier,
and primarily engages in the import and export business of products such as pc,ail,ice.
According to the 52wmb.com global trade database, as of 2026-03-30, the company has completed 126 international trades,
with its main trading regions covering united states,czech republic,china etc.
The core products include HS30024200,HS90279000,HS39269040 etc,
often transported via lpaf,port ipaf, port kaps etc,
and its main trading partners are vicam a waters,bioveta,bioveta a.s..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on m s snam pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.